Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 96th Annual Meeting of the Japanese Pharmacological Society
Session ID : 96_3-B-S31-2
Conference information

Symposium
Aging, epigenome, and partial reprogramming
*Taro Toyoda
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

Aging is the gradual but progressive decline of physiological function in cellular and tissue levels, eventually leading to the disruption of homeostasis in an individual organism. Advancing age is known to be one of the risk factors for various diseases and mortality, but the quantification and intervention are challenging. Aging hallmarks are well characterized while they are not exclusively specific to aging, and dependent on context, cell type and disease state. In addition, aging process is used to be considered as unidirectional. However, the generation of iPS cells demonstrates that terminally differentiated somatic cells can be reverted to embryonic like state while keeping genetic information. Owing to going through the iPS cell state, we can obtain rejuvenated phenotype of cells and tissues. Intriguingly, vigorous research for understanding the iPS cell reprogramming process has also demonstrated that the partial reprogramming reverses many age-associated changes without going through iPS cell state. In this presentation, I will introduce and discuss the potential of partial reprogramming against age-associated changes and the process which gives insight for the mechanisms.

Content from these authors
© 2022 The Authors(s)
Previous article Next article
feedback
Top